Advanced search
Publication Cover
Acta Cardiologica Volume 66, 2011 - Issue 5
Submit an article Journal homepage
7
Views
8
CrossRef citations to date
0
Altmetric
Articles

Potassium supplement ameliorates salt-induced haemostatic abnormalities in normotensive subjects

Fuqiang LiuDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Phd,
Jianjun MuDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. ChinaCorrespondence[email protected]
, Phd,
Zuyi YuanDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Phd,
Min ZhangDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Md,
Shuhui Zheng
, Phd,
Qiufang LianDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Phd,
Enqi LiuLaboratory Animal Centre, Xi’an Jiaotong University of Medical College; Xi’an, P. R. China;Department of Molecular Pathology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Yamanashi, Japan.
, Phd,
Haixia XuDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Md,
Keyu RenDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Md &
Qiang HuangDepartment of Cardiovascular Medicine, First Affi liated Hospital of Medical College, P. R. China
, Md show all
Pages 635-639 | Received 22 Feb 2010, Accepted 30 Mar 2010, Published online: 23 May 2017

References

  • Muntzel M, Dffjeke T. A comprehensive review of the salt and blood pressure relationship. Am J Hypertens 1992; 5: 1S-42S.
  • He FJ, MacGregor GA. Salt, blood pressure and cardiovascular disease. Curr Opin Cardiol 2007; 22: 298–305.
  • Cook NR. Salt intake, blood pressure and clinical outcomes. Curr Opin Nephrol Hypertens 2008; 17: 310–4.
  • Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials. J Hum Hypertens 2003; 17:471–80.
  • Qin X, Jackson R, Marshall R, Lee LM, Cao WH, Zhan SY, Hu YH. Modelling the potential impact of population-wide and targetedhigh-risk blood pressure-lowering strategies on cardiovascular disease in China. Eur J Cardiovasc Prey Rehabil 2009; 16:96–101.
  • Mu J, Liu Z, Liu F, Xu X, Liang Y, Zhu D. Family-based randomized trial to detect effects on blood pressure of a salt substitute containing potassium and calcium in hypertensive adolescents. Am J Hypertens 2009; 22: 943–7.
  • Umesawa M, lso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi 5, Koizumi A, Kondo T, Inaba Y, Tanabe N, Tamakoshi A. Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study forEvaluation of Cancer Risks. Am J Clin Nutr 2008; 88: 195–202.
  • Sasaki 5, Zhang XH, Kesteloot H. Dietary sodium, potassium, saturated fat, alcohol, and stroke mortality. Stroke 1995; 26: 783–9.
  • Strazzullo PD, Lanfranco Kandala NC, Francesco P. Salt intake, stroke, and cardiovascular disease:meta-analysis of prospective studies. BMJ 2009; 339: b4567 (abstract).
  • He J, Ogden LG, Vupputuri 5, Bazzano LA, Loria C, Whelton PK. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA 1999; 282: 2027–34.
  • Cook NR, Obarzanek E, Cutler JA, Buring JE, Rexrode KM, Kumanyika SK, Appel U, Whelton PK. Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. Arch Intern Med 2009; 169:32–40.
  • Dickinson HO, Nicolson DJ, Campbell F, Beyer FR, Mason J. Potassium supplementation for the management of primary hypertension in adults. Cochrane Database Syst Rev 2006; 3: CD004641.
  • Perry IJ, Beevers DG. Salt intake and stroke: a possible direct effect. J Hum Hypertens 1992; 6: 23–5.
  • Tobian L, Hanlon S. High sodium chloride diets injure arteries and raise mortality without changing blood pressure. Hypertension 1990; 15: 900–3.
  • du Cailar G, Mimran A. Non-pressure-related effects of dietary sodium. Curr Hypertens Rep 2009; 11: 12–7.
  • Lip GY, Blann AD, Edmunds E, Beevers DG. Baseline abnormalities of endothelial function and thrombogenesis in relation to prognosis in essential hypertension. Blood Coagul Fibrinolysis 2002; 13: 35–41.
  • Ageno W, Finazzi 5, Steidl L, Biotti MG, Mera V. Melzi DG, Venco A. Plasma measurement of D-dimer levels for the early diagnosis of ischemic stroke subtypes. Arch Intern Med 2008; 162: 2589–93.
  • Maresca G, Di BA, Marchioli R, Di MG. Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 1999; 19: 1368–77.
  • Fang Y, Mu JJ, He LC, Wang SC, Liu ZQ. Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive Asians. Hypertension 2006; 48: 724–9.
  • Nagata C, Takatsuka N, Shimizu N, Shimizu H. Sodium intake and riskof death from stroke in Japanese men and women. Stroke 2004; 35: 1543–7.
  • Khaw KT, Barrett-Connor E.Dietary potassium and stroke-associated mortality. A 12-year prospective population study. N Engl J Med 1987; 316:235–40.
  • Bazzano LA, He J, Ogden LG, Loria C, Vupputuri 5, Myers L, Whelton PK. Dietary potassium intake and risk of stroke in US men and women:National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke 2001; 32:1473–80.
  • Whelton PK, He J, Appel U, Cutler JA, Havas 5, Kotchen TA, Roccella EJ, Stout R, Vallbona C, Winston MC, Karimbakas J.Primary prevention of hypertension:clinical and public health advisory fromThe National High Blood Pressure Education Program. JAMA 2002; 288:1882–8.
  • Barber M, Langhorne P. Rumley A, Lowe GD, Stott DJ. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke 2004; 35: 1421–5.
  • Jansson JH, Nilsson TK, Johnson 0.von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br HeartJ 1991; 66:351–5.
  • Spiel AO, Gilbert JC, Jilma B.von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes. Circulation 2008; 117: 1449–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Novo Nordisk – Driving change to defeat serious chronic diseases.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.